Deerfield Management Company, L.P.

Institutional investor · Portfolio as of Q4 2021

Q4 2021 biggest moves
  • AHCOAHCO

    AdaptHealth

    Added 26%

    now 5.2% of portfolio

  • DCPHDCPH

    DECIPHERA PHARMACEUTICALS IN

    6.8× the shares

    now 1.1% of portfolio

  • BDSIBDSI

    BIODELIVERY SCIENCES INTL

    Cut 99.7%

    now 0.0% of portfolio

  • VTRSVTRS

    Viatris

    Added 10%

    now 5.9% of portfolio

93 changes in all

Top Holdings127 positions

Checking export access…
Activity:
NUVL
NUVLDelisted

NUVALENT INC

19.3M$368.3M7.7%——
2 qtrssince 2021-Q3
Unchanged
0
VTRS

Viatris Inc.

20.8M$281.1M5.9%$14.06-21.34%
5 qtrssince 2020-Q4
Increased
66
AHCO

AdaptHealth Corp.

10.2M$250.1M5.2%$24.61-0.62%
9 qtrssince 2019-Q4
Increased
74
??
GLAUKOS CORPDelisted
Bond
204.7M$242.4M5.1%——
3 qtrssince 2021-Q2
Increased
94
??
INVITAE CORPDelisted
Bond
163.4M$153.3M3.2%——
6 qtrssince 2020-Q3
Unchanged
0
157.4M$130.2M2.7%——
6 qtrssince 2020-Q3
Unchanged
0
??
CAREMAX INCDelisted
16.8M$128.9M2.7%——
3 qtrssince 2021-Q2
Unchanged
0
NBIX

Neurocrine Biosciences, Inc.

1.4M$117.4M2.5%$94.78-10.14%
4 qtrssince 2021-Q1
Increased
61
52.5M$116.5M2.4%——
3 qtrssince 2021-Q2
Unchanged
0
??
NATERA INCDelisted
Bond
45M$115.8M2.4%——
3 qtrssince 2021-Q2
Unchanged
0
OMIC
OMICDelisted

SINGULAR GENOMICS SYSTEMS IN

9.1M$105.3M2.2%——
3 qtrssince 2021-Q2
Unchanged
0
??
NUVASIVE INCDelisted
Bond
97M$96.6M2.0%——
3 qtrssince 2021-Q2
Unchanged
0
81.6M$90.5M1.9%——
2 qtrssince 2021-Q3
Unchanged
0
CNC

Centene Corporation

1M$82.7M1.7%$60.27+36.73%
9 qtrssince 2019-Q4
Unchanged
0
97.8M$80.5M1.7%——
4 qtrssince 2021-Q1
Increased
76
ISEE
ISEEDelisted

IVERIC BIO INC

4.8M$79.6M1.7%——
9 qtrssince 2019-Q4
Decreased
0
ORGO

Organogenesis Holdings Inc.

8.5M$78.1M1.6%$16.25-43.14%
4 qtrssince 2021-Q1
Increased
53
??
INSULET CORPDelisted
Bond
57.6M$76.4M1.6%——
5 qtrssince 2020-Q4
Unchanged
0
LUNG

Pulmonx Corporation

2.4M$75.9M1.6%$46.82-31.50%
5 qtrssince 2020-Q4
Increased
54
??
NUVASIVE INCDelisted
Bond
77.9M$74.7M1.6%——
4 qtrssince 2021-Q1
Increased
62
$4.8B
AUM
127
Positions
Q4 2021
Filing
HI rating · 1.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2020-Q3$4,106,901,00019.5991889075%
2020-Q4$5,059,782,00023.2019471616%
2021-Q1$4,758,345,000-5.95750963184%
2021-Q2$5,629,668,00018.3114717407%
2021-Q3$5,123,921,000-8.98360258545%
2021-Q4$4,767,581,000-6.95443977376%
Activity profile
$ moved · Q4'21
New21%Increased32%Decreased19%Exited28%
Composition
Equity vs derivatives
Equity>99%Puts0%Calls<1%
Holding period
Avg 3.4 quarters
<1Q18%1-4Q39%1-2Y28%2Y+16%

Deerfield Management Company, L.P. manages $4.8B across 127 positions as of Q4 2021. Top holdings: NUVL (7.7%), VTRS (5.9%), AHCO (5.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Top holdings by portfolio weight

Total AUM$5B
NUVL7.72%
VTRS5.90%
AHCO5.25%
GLAUKOS CORP5.09%
INVITAE CORP3.22%
AERIE PHARMA2.73%
CAREMAX INC2.70%
NBIX2.46%
ENVISTA HOLD2.44%
NATERA INC2.43%
Other2.21%

Portfolio allocation by GICS sector

Sectors3
Healthcare75.55%
Unknown23.69%
Consumer Cyclical0.75%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L32
Conviction55
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
BCRXBCRXBioCryst Pharmaceuticals, Inc.
Q3 2025 → Q3 2026+10.8M shares+$87M
3Q
TNGXTNGXTango Therapeutics, Inc.
Q1 2026 → Q3 2026+2.3M shares+$103.5M
2Q
BMRNBMRNBioMarin Pharmaceutical Inc.
Q2 2026 → Q3 2026+1.2M shares+$73.4M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used